• +91 9169164321 (Asia)
  • +1(646)-781-7170 (Int'l)
  • help@24lifesciences.com
Cart (0)

Global Hereditary Angioedema Market Insights and Forecast to 2026

report cover
  • 31 July 2020
  • Pharmaceuticals
  • 117 Pages
  • Report Code: 24LS-16398
  • Formate :   
Download FREE Report Sample Download PDF File

Hereditary Angioedema -MARKET ADVISORY SERVICES

Hereditary Angioedema market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Hereditary Angioedema market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Hereditary Angioedema market is segmented into
C1 Esterase Inhibitor
Kallikrein Inhibitor
Selective Bradykinin B2 Receptor Antagonist

Segment by Application, the Hereditary Angioedema market is segmented into
Retail Pharmacies
Hospital Pharmacies
Online Pharmacies

Regional and Country-level Analysis
The Hereditary Angioedema market is analysed and market size information is provided by regions (countries).
The key regions covered in the Hereditary Angioedema market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Hereditary Angioedema Market Share Analysis
Hereditary Angioedema market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Hereditary Angioedema business, the date to enter into the Hereditary Angioedema market, Hereditary Angioedema product introduction, recent developments, etc.

The major vendors covered:
Pharming Group NV
Takeda
CSL Limited
iBio Inc.
BioCryst Pharmaceuticals, Inc.
Ionis Pharmaceuticals, Inc.
...
1 Study Coverage
1.1 Hereditary Angioedema Product Introduction
1.2 Market Segments
1.3 Key Hereditary Angioedema Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Hereditary Angioedema Market Size Growth Rate by Type
1.4.2 C1 Esterase Inhibitor
1.4.3 Kallikrein Inhibitor
1.4.4 Selective Bradykinin B2 Receptor Antagonist
1.5 Market by Application
1.5.1 Global Hereditary Angioedema Market Size Growth Rate by Application
1.5.2 Retail Pharmacies
1.5.3 Hospital Pharmacies
1.5.4 Online Pharmacies
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Hereditary Angioedema Market Size, Estimates and Forecasts
2.1.1 Global Hereditary Angioedema Revenue 2015-2026
2.1.2 Global Hereditary Angioedema Sales 2015-2026
2.2 Global Hereditary Angioedema, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Hereditary Angioedema Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Hereditary Angioedema Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Hereditary Angioedema Competitor Landscape by Players
3.1 Hereditary Angioedema Sales by Manufacturers
3.1.1 Hereditary Angioedema Sales by Manufacturers (2015-2020)
3.1.2 Hereditary Angioedema Sales Market Share by Manufacturers (2015-2020)
3.2 Hereditary Angioedema Revenue by Manufacturers
3.2.1 Hereditary Angioedema Revenue by Manufacturers (2015-2020)
3.2.2 Hereditary Angioedema Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Hereditary Angioedema Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Hereditary Angioedema Revenue in 2019
3.2.5 Global Hereditary Angioedema Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Hereditary Angioedema Price by Manufacturers
3.4 Hereditary Angioedema Manufacturing Base Distribution, Product Types
3.4.1 Hereditary Angioedema Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Hereditary Angioedema Product Type
3.4.3 Date of International Manufacturers Enter into Hereditary Angioedema Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Hereditary Angioedema Market Size by Type (2015-2020)
4.1.1 Global Hereditary Angioedema Sales by Type (2015-2020)
4.1.2 Global Hereditary Angioedema Revenue by Type (2015-2020)
4.1.3 Hereditary Angioedema Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Hereditary Angioedema Market Size Forecast by Type (2021-2026)
4.2.1 Global Hereditary Angioedema Sales Forecast by Type (2021-2026)
4.2.2 Global Hereditary Angioedema Revenue Forecast by Type (2021-2026)
4.2.3 Hereditary Angioedema Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Hereditary Angioedema Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)
5.1 Global Hereditary Angioedema Market Size by Application (2015-2020)
5.1.1 Global Hereditary Angioedema Sales by Application (2015-2020)
5.1.2 Global Hereditary Angioedema Revenue by Application (2015-2020)
5.1.3 Hereditary Angioedema Price by Application (2015-2020)
5.2 Hereditary Angioedema Market Size Forecast by Application (2021-2026)
5.2.1 Global Hereditary Angioedema Sales Forecast by Application (2021-2026)
5.2.2 Global Hereditary Angioedema Revenue Forecast by Application (2021-2026)
5.2.3 Global Hereditary Angioedema Price Forecast by Application (2021-2026)

6 North America
6.1 North America Hereditary Angioedema by Country
6.1.1 North America Hereditary Angioedema Sales by Country
6.1.2 North America Hereditary Angioedema Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Hereditary Angioedema Market Facts & Figures by Type
6.3 North America Hereditary Angioedema Market Facts & Figures by Application

7 Europe
7.1 Europe Hereditary Angioedema by Country
7.1.1 Europe Hereditary Angioedema Sales by Country
7.1.2 Europe Hereditary Angioedema Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Hereditary Angioedema Market Facts & Figures by Type
7.3 Europe Hereditary Angioedema Market Facts & Figures by Application

8 Asia Pacific
8.1 Asia Pacific Hereditary Angioedema by Region
8.1.1 Asia Pacific Hereditary Angioedema Sales by Region
8.1.2 Asia Pacific Hereditary Angioedema Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Hereditary Angioedema Market Facts & Figures by Type
8.3 Asia Pacific Hereditary Angioedema Market Facts & Figures by Application

9 Latin America
9.1 Latin America Hereditary Angioedema by Country
9.1.1 Latin America Hereditary Angioedema Sales by Country
9.1.2 Latin America Hereditary Angioedema Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Hereditary Angioedema Market Facts & Figures by Type
9.3 Central & South America Hereditary Angioedema Market Facts & Figures by Application

10 Middle East and Africa
10.1 Middle East and Africa Hereditary Angioedema by Country
10.1.1 Middle East and Africa Hereditary Angioedema Sales by Country
10.1.2 Middle East and Africa Hereditary Angioedema Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Hereditary Angioedema Market Facts & Figures by Type
10.3 Middle East and Africa Hereditary Angioedema Market Facts & Figures by Application

11 Company Profiles
11.1 Pharming Group NV
11.1.1 Pharming Group NV Corporation Information
11.1.2 Pharming Group NV Description and Business Overview
11.1.3 Pharming Group NV Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Pharming Group NV Hereditary Angioedema Products Offered
11.1.5 Pharming Group NV Related Developments
11.2 Takeda
11.2.1 Takeda Corporation Information
11.2.2 Takeda Description and Business Overview
11.2.3 Takeda Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Takeda Hereditary Angioedema Products Offered
11.2.5 Takeda Related Developments
11.3 CSL Limited
11.3.1 CSL Limited Corporation Information
11.3.2 CSL Limited Description and Business Overview
11.3.3 CSL Limited Sales, Revenue and Gross Margin (2015-2020)
11.3.4 CSL Limited Hereditary Angioedema Products Offered
11.3.5 CSL Limited Related Developments
11.4 iBio Inc.
11.4.1 iBio Inc. Corporation Information
11.4.2 iBio Inc. Description and Business Overview
11.4.3 iBio Inc. Sales, Revenue and Gross Margin (2015-2020)
11.4.4 iBio Inc. Hereditary Angioedema Products Offered
11.4.5 iBio Inc. Related Developments
11.5 BioCryst Pharmaceuticals, Inc.
11.5.1 BioCryst Pharmaceuticals, Inc. Corporation Information
11.5.2 BioCryst Pharmaceuticals, Inc. Description and Business Overview
11.5.3 BioCryst Pharmaceuticals, Inc. Sales, Revenue and Gross Margin (2015-2020)
11.5.4 BioCryst Pharmaceuticals, Inc. Hereditary Angioedema Products Offered
11.5.5 BioCryst Pharmaceuticals, Inc. Related Developments
11.6 Ionis Pharmaceuticals, Inc.
11.6.1 Ionis Pharmaceuticals, Inc. Corporation Information
11.6.2 Ionis Pharmaceuticals, Inc. Description and Business Overview
11.6.3 Ionis Pharmaceuticals, Inc. Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Ionis Pharmaceuticals, Inc. Hereditary Angioedema Products Offered
11.6.5 Ionis Pharmaceuticals, Inc. Related Developments
11.1 Pharming Group NV
11.1.1 Pharming Group NV Corporation Information
11.1.2 Pharming Group NV Description and Business Overview
11.1.3 Pharming Group NV Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Pharming Group NV Hereditary Angioedema Products Offered
11.1.5 Pharming Group NV Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Hereditary Angioedema Market Estimates and Projections by Region
12.1.1 Global Hereditary Angioedema Sales Forecast by Regions 2021-2026
12.1.2 Global Hereditary Angioedema Revenue Forecast by Regions 2021-2026
12.2 North America Hereditary Angioedema Market Size Forecast (2021-2026)
12.2.1 North America: Hereditary Angioedema Sales Forecast (2021-2026)
12.2.2 North America: Hereditary Angioedema Revenue Forecast (2021-2026)
12.2.3 North America: Hereditary Angioedema Market Size Forecast by Country (2021-2026)
12.3 Europe Hereditary Angioedema Market Size Forecast (2021-2026)
12.3.1 Europe: Hereditary Angioedema Sales Forecast (2021-2026)
12.3.2 Europe: Hereditary Angioedema Revenue Forecast (2021-2026)
12.3.3 Europe: Hereditary Angioedema Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Hereditary Angioedema Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Hereditary Angioedema Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Hereditary Angioedema Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Hereditary Angioedema Market Size Forecast by Region (2021-2026)
12.5 Latin America Hereditary Angioedema Market Size Forecast (2021-2026)
12.5.1 Latin America: Hereditary Angioedema Sales Forecast (2021-2026)
12.5.2 Latin America: Hereditary Angioedema Revenue Forecast (2021-2026)
12.5.3 Latin America: Hereditary Angioedema Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Hereditary Angioedema Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Hereditary Angioedema Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Hereditary Angioedema Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Hereditary Angioedema Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Hereditary Angioedema Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Hereditary Angioedema Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables

Table 1. Hereditary Angioedema Market Segments

Table 2. Ranking of Global Top Hereditary Angioedema Manufacturers by Revenue (US$ Million) in 2019

Table 3. Global Hereditary Angioedema Market Size Growth Rate by Type 2020-2026 (MT) & (US$ Million)

Table 4. Major Manufacturers of C1 Esterase Inhibitor

Table 5. Major Manufacturers of Kallikrein Inhibitor

Table 6. Major Manufacturers of Selective Bradykinin B2 Receptor Antagonist

Table 7. Global Hereditary Angioedema Market Size Growth Rate by Application 2020-2026 (MT)

Table 8. Global Hereditary Angioedema Market Size by Region (MT) & (US$ Million): 2020 VS 2026

Table 9. Global Hereditary Angioedema Sales by Regions 2015-2020 (MT)

Table 10. Global Hereditary Angioedema Sales Market Share by Regions (2015-2020)

Table 11. Global Hereditary Angioedema Revenue by Regions 2015-2020 (US$ Million)

Table 12. Global Hereditary Angioedema Sales by Manufacturers (2015-2020) (MT)

Table 13. Global Hereditary Angioedema Sales Share by Manufacturers (2015-2020)

Table 14. Global Hereditary Angioedema Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)

Table 15. Global Hereditary Angioedema by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hereditary Angioedema as of 2019)

Table 16. Hereditary Angioedema Revenue by Manufacturers (2015-2020) (US$ Million)

Table 17. Hereditary Angioedema Revenue Share by Manufacturers (2015-2020)

Table 18. Key Manufacturers Hereditary Angioedema Price (2015-2020) (USD/Kg)

Table 19. Hereditary Angioedema Manufacturers Manufacturing Base Distribution and Headquarters

Table 20. Manufacturers Hereditary Angioedema Product Type

Table 21. Date of International Manufacturers Enter into Hereditary Angioedema Market

Table 22. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 23. Global Hereditary Angioedema Sales by Type (2015-2020) (MT)

Table 24. Global Hereditary Angioedema Sales Share by Type (2015-2020)

Table 25. Global Hereditary Angioedema Revenue by Type (2015-2020) (US$ Million)

Table 26. Global Hereditary Angioedema Revenue Share by Type (2015-2020)

Table 27. Hereditary Angioedema Average Selling Price (ASP) by Type 2015-2020 (USD/Kg)

Table 28. Global Hereditary Angioedema Sales by Application (2015-2020) (MT)

Table 29. Global Hereditary Angioedema Sales Share by Application (2015-2020)

Table 30. North America Hereditary Angioedema Sales by Country (2015-2020) (MT)

Table 31. North America Hereditary Angioedema Sales Market Share by Country (2015-2020)

Table 32. North America Hereditary Angioedema Revenue by Country (2015-2020) (US$ Million)

Table 33. North America Hereditary Angioedema Revenue Market Share by Country (2015-2020)

Table 34. North America Hereditary Angioedema Sales by Type (2015-2020) (MT)

Table 35. North America Hereditary Angioedema Sales Market Share by Type (2015-2020)

Table 36. North America Hereditary Angioedema Sales by Application (2015-2020) (MT)

Table 37. North America Hereditary Angioedema Sales Market Share by Application (2015-2020)

Table 38. Europe Hereditary Angioedema Sales by Country (2015-2020) (MT)

Table 39. Europe Hereditary Angioedema Sales Market Share by Country (2015-2020)

Table 40. Europe Hereditary Angioedema Revenue by Country (2015-2020) (US$ Million)

Table 41. Europe Hereditary Angioedema Revenue Market Share by Country (2015-2020)

Table 42. Europe Hereditary Angioedema Sales by Type (2015-2020) (MT)

Table 43. Europe Hereditary Angioedema Sales Market Share by Type (2015-2020)

Table 44. Europe Hereditary Angioedema Sales by Application (2015-2020) (MT)

Table 45. Europe Hereditary Angioedema Sales Market Share by Application (2015-2020)

Table 46. Asia Pacific Hereditary Angioedema Sales by Region (2015-2020) (MT)

Table 47. Asia Pacific Hereditary Angioedema Sales Market Share by Region (2015-2020)

Table 48. Asia Pacific Hereditary Angioedema Revenue by Region (2015-2020) (US$ Million)

Table 49. Asia Pacific Hereditary Angioedema Revenue Market Share by Region (2015-2020)

Table 50. Asia Pacific Hereditary Angioedema Sales by Type (2015-2020) (MT)

Table 51. Asia Pacific Hereditary Angioedema Sales Market Share by Type (2015-2020)

Table 52. Asia Pacific Hereditary Angioedema Sales by Application (2015-2020) (MT)

Table 53. Asia Pacific Hereditary Angioedema Sales Market Share by Application (2015-2020)

Table 54. Latin America Hereditary Angioedema Sales by Country (2015-2020) (MT)

Table 55. Latin America Hereditary Angioedema Sales Market Share by Country (2015-2020)

Table 56. Latin Americaa Hereditary Angioedema Revenue by Country (2015-2020) (US$ Million)

Table 57. Latin America Hereditary Angioedema Revenue Market Share by Country (2015-2020)

Table 58. Latin America Hereditary Angioedema Sales by Type (2015-2020) (MT)

Table 59. Latin America Hereditary Angioedema Sales Market Share by Type (2015-2020)

Table 60. Latin America Hereditary Angioedema Sales by Application (2015-2020) (MT)

Table 61. Latin America Hereditary Angioedema Sales Market Share by Application (2015-2020)

Table 62. Middle East and Africa Hereditary Angioedema Sales by Country (2015-2020) (MT)

Table 63. Middle East and Africa Hereditary Angioedema Sales Market Share by Country (2015-2020)

Table 64. Middle East and Africa Hereditary Angioedema Revenue by Country (2015-2020) (US$ Million)

Table 65. Middle East and Africa Hereditary Angioedema Revenue Market Share by Country (2015-2020)

Table 66. Middle East and Africa Hereditary Angioedema Sales by Type (2015-2020) (MT)

Table 67. Middle East and Africa Hereditary Angioedema Sales Market Share by Type (2015-2020)

Table 68. Middle East and Africa Hereditary Angioedema Sales by Application (2015-2020) (MT)

Table 69. Middle East and Africa Hereditary Angioedema Sales Market Share by Application (2015-2020)

Table 70. Pharming Group NV Corporation Information

Table 71. Pharming Group NV Description and Major Businesses

Table 72. Pharming Group NV Hereditary Angioedema Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)

Table 73. Pharming Group NV Product

Table 74. Pharming Group NV Recent Development

Table 75. Takeda Corporation Information

Table 76. Takeda Description and Major Businesses

Table 77. Takeda Hereditary Angioedema Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)

Table 78. Takeda Product

Table 79. Takeda Recent Development

Table 80. CSL Limited Corporation Information

Table 81. CSL Limited Description and Major Businesses

Table 82. CSL Limited Hereditary Angioedema Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)

Table 83. CSL Limited Product

Table 84. CSL Limited Recent Development

Table 85. iBio Inc. Corporation Information

Table 86. iBio Inc. Description and Major Businesses

Table 87. iBio Inc. Hereditary Angioedema Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)

Table 88. iBio Inc. Product

Table 89. iBio Inc. Recent Development

Table 90. BioCryst Pharmaceuticals, Inc. Corporation Information

Table 91. BioCryst Pharmaceuticals, Inc. Description and Major Businesses

Table 92. BioCryst Pharmaceuticals, Inc. Hereditary Angioedema Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)

Table 93. BioCryst Pharmaceuticals, Inc. Product

Table 94. BioCryst Pharmaceuticals, Inc. Recent Development

Table 95. Ionis Pharmaceuticals, Inc. Corporation Information

Table 96. Ionis Pharmaceuticals, Inc. Description and Major Businesses

Table 97. Ionis Pharmaceuticals, Inc. Hereditary Angioedema Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)

Table 98. Ionis Pharmaceuticals, Inc. Product

Table 99. Ionis Pharmaceuticals, Inc. Recent Development

Table 100. Global Hereditary Angioedema Sales Forecast by Regions (2021-2026) (MT)

Table 101. Global Hereditary Angioedema Sales Market Share Forecast by Regions (2021-2026)

Table 102. Global Hereditary Angioedema Revenue Forecast by Regions (2021-2026) (US$ Million)

Table 103. Global Hereditary Angioedema Revenue Market Share Forecast by Regions (2021-2026)

Table 104. North America: Hereditary Angioedema Sales Forecast by Country (2021-2026) (MT)

Table 105. North America: Hereditary Angioedema Revenue Forecast by Country (2021-2026) (US$ Million)

Table 106. Europe: Hereditary Angioedema Sales Forecast by Country (2021-2026) (MT)

Table 107. Europe: Hereditary Angioedema Revenue Forecast by Country (2021-2026) (US$ Million)

Table 108. Asia Pacific: Hereditary Angioedema Sales Forecast by Region (2021-2026) (MT)

Table 109. Asia Pacific: Hereditary Angioedema Revenue Forecast by Region (2021-2026) (US$ Million)

Table 110. Latin America: Hereditary Angioedema Sales Forecast by Country (2021-2026) (MT)

Table 111. Latin America: Hereditary Angioedema Revenue Forecast by Country (2021-2026) (US$ Million)

Table 112. Middle East and Africa: Hereditary Angioedema Sales Forecast by Country (2021-2026) (MT)

Table 113. Middle East and Africa: Hereditary Angioedema Revenue Forecast by Country (2021-2026) (US$ Million)

Table 114. Key Opportunities and Drivers: Impact Analysis (2021-2026)

Table 115. Key Challenges

Table 116. Market Risks

Table 117. Main Points Interviewed from Key Hereditary Angioedema Players

Table 118. Hereditary Angioedema Customers List

Table 119. Hereditary Angioedema Distributors List

Table 120. Research Programs/Design for This Report

Table 121. Key Data Information from Secondary Sources

Table 122. Key Data Information from Primary Sources

List of Figures

Figure 1. Hereditary Angioedema Product Picture

Figure 2. Global Hereditary Angioedema Sales Market Share by Type in 2020 & 2026

Figure 3. C1 Esterase Inhibitor Product Picture

Figure 4. Kallikrein Inhibitor Product Picture

Figure 5. Selective Bradykinin B2 Receptor Antagonist Product Picture

Figure 6. Global Hereditary Angioedema Sales Market Share by Application in 2020 & 2026

Figure 7. Retail Pharmacies

Figure 8. Hospital Pharmacies

Figure 9. Online Pharmacies

Figure 10. Hereditary Angioedema Report Years Considered

Figure 11. Global Hereditary Angioedema Market Size 2015-2026 (US$ Million)

Figure 12. Global Hereditary Angioedema Sales 2015-2026 (MT)

Figure 13. Global Hereditary Angioedema Market Size Market Share by Region: 2020 Versus 2026

Figure 14. Global Hereditary Angioedema Sales Market Share by Region (2015-2020)

Figure 15. Global Hereditary Angioedema Sales Market Share by Region in 2019

Figure 16. Global Hereditary Angioedema Revenue Market Share by Region (2015-2020)

Figure 17. Global Hereditary Angioedema Revenue Market Share by Region in 2019

Figure 18. Global Hereditary Angioedema Sales Share by Manufacturer in 2019

Figure 19. The Top 10 and 5 Players Market Share by Hereditary Angioedema Revenue in 2019

Figure 20. Hereditary Angioedema Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019

Figure 21. Global Hereditary Angioedema Sales Market Share by Type (2015-2020)

Figure 22. Global Hereditary Angioedema Sales Market Share by Type in 2019

Figure 23. Global Hereditary Angioedema Revenue Market Share by Type (2015-2020)

Figure 24. Global Hereditary Angioedema Revenue Market Share by Type in 2019

Figure 25. Global Hereditary Angioedema Market Share by Price Range (2015-2020)

Figure 26. Global Hereditary Angioedema Sales Market Share by Application (2015-2020)

Figure 27. Global Hereditary Angioedema Sales Market Share by Application in 2019

Figure 28. Global Hereditary Angioedema Revenue Market Share by Application (2015-2020)

Figure 29. Global Hereditary Angioedema Revenue Market Share by Application in 2019

Figure 30. North America Hereditary Angioedema Sales Growth Rate 2015-2020 (MT)

Figure 31. North America Hereditary Angioedema Revenue Growth Rate 2015-2020 (US$ Million)

Figure 32. North America Hereditary Angioedema Sales Market Share by Country in 2019

Figure 33. North America Hereditary Angioedema Revenue Market Share by Country in 2019

Figure 34. U.S. Hereditary Angioedema Sales Growth Rate (2015-2020) (MT)

Figure 35. U.S. Hereditary Angioedema Revenue Growth Rate (2015-2020) (US$ Million)

Figure 36. Canada Hereditary Angioedema Sales Growth Rate (2015-2020) (MT)

Figure 37. Canada Hereditary Angioedema Revenue Growth Rate (2015-2020) (US$ Million)

Figure 38. North America Hereditary Angioedema Market Share by Type in 2019

Figure 39. North America Hereditary Angioedema Market Share by Application in 2019

Figure 40. Europe Hereditary Angioedema Sales Growth Rate 2015-2020 (MT)

Figure 41. Europe Hereditary Angioedema Revenue Growth Rate 2015-2020 (US$ Million)

Figure 42. Europe Hereditary Angioedema Sales Market Share by Country in 2019

Figure 43. Europe Hereditary Angioedema Revenue Market Share by Country in 2019

Figure 44. Germany Hereditary Angioedema Sales Growth Rate (2015-2020) (MT)

Figure 45. Germany Hereditary Angioedema Revenue Growth Rate (2015-2020) (US$ Million)

Figure 46. France Hereditary Angioedema Sales Growth Rate (2015-2020) (MT)

Figure 47. France Hereditary Angioedema Revenue Growth Rate (2015-2020) (US$ Million)

Figure 48. U.K. Hereditary Angioedema Sales Growth Rate (2015-2020) (MT)

Figure 49. U.K. Hereditary Angioedema Revenue Growth Rate (2015-2020) (US$ Million)

Figure 50. Italy Hereditary Angioedema Sales Growth Rate (2015-2020) (MT)

Figure 51. Italy Hereditary Angioedema Revenue Growth Rate (2015-2020) (US$ Million)

Figure 52. Russia Hereditary Angioedema Sales Growth Rate (2015-2020) (MT)

Figure 53. Russia Hereditary Angioedema Revenue Growth Rate (2015-2020) (US$ Million)

Figure 54. Europe Hereditary Angioedema Market Share by Type in 2019

Figure 55. Europe Hereditary Angioedema Market Share by Application in 2019

Figure 56. Asia Pacific Hereditary Angioedema Sales Growth Rate 2015-2020 (MT)

Figure 57. Asia Pacific Hereditary Angioedema Revenue Growth Rate 2015-2020 (US$ Million)

Figure 58. Asia Pacific Hereditary Angioedema Sales Market Share by Region in 2019

Figure 59. Asia Pacific Hereditary Angioedema Revenue Market Share by Region in 2019

Figure 60. China Hereditary Angioedema Sales Growth Rate (2015-2020) (MT)

Figure 61. China Hereditary Angioedema Revenue Growth Rate (2015-2020) (US$ Million)

Figure 62. Japan Hereditary Angioedema Sales Growth Rate (2015-2020) (MT)

Figure 63. Japan Hereditary Angioedema Revenue Growth Rate (2015-2020) (US$ Million)

Figure 64. South Korea Hereditary Angioedema Sales Growth Rate (2015-2020) (MT)

Figure 65. South Korea Hereditary Angioedema Revenue Growth Rate (2015-2020) (US$ Million)

Figure 66. India Hereditary Angioedema Sales Growth Rate (2015-2020) (MT)

Figure 67. India Hereditary Angioedema Revenue Growth Rate (2015-2020) (US$ Million)

Figure 68. Australia Hereditary Angioedema Sales Growth Rate (2015-2020) (MT)

Figure 69. Australia Hereditary Angioedema Revenue Growth Rate (2015-2020) (US$ Million)

Figure 70. Taiwan Hereditary Angioedema Sales Growth Rate (2015-2020) (MT)

Figure 71. Taiwan Hereditary Angioedema Revenue Growth Rate (2015-2020) (US$ Million)

Figure 72. Indonesia Hereditary Angioedema Sales Growth Rate (2015-2020) (MT)

Figure 73. Indonesia Hereditary Angioedema Revenue Growth Rate (2015-2020) (US$ Million)

Figure 74. Thailand Hereditary Angioedema Sales Growth Rate (2015-2020) (MT)

Figure 75. Thailand Hereditary Angioedema Revenue Growth Rate (2015-2020) (US$ Million)

Figure 76. Malaysia Hereditary Angioedema Sales Growth Rate (2015-2020) (MT)

Figure 77. Malaysia Hereditary Angioedema Revenue Growth Rate (2015-2020) (US$ Million)

Figure 78. Philippines Hereditary Angioedema Sales Growth Rate (2015-2020) (MT)

Figure 79. Philippines Hereditary Angioedema Revenue Growth Rate (2015-2020) (US$ Million)

Figure 80. Vietnam Hereditary Angioedema Sales Growth Rate (2015-2020) (MT)

Figure 81. Vietnam Hereditary Angioedema Revenue Growth Rate (2015-2020) (US$ Million)

Figure 82. Asia Pacific Hereditary Angioedema Market Share by Type in 2019

Figure 83. Asia Pacific Hereditary Angioedema Market Share by Application in 2019

Figure 84. Latin America Hereditary Angioedema Sales Growth Rate 2015-2020 (MT)

Figure 85. Latin America Hereditary Angioedema Revenue Growth Rate 2015-2020 (US$ Million)

Figure 86. Latin America Hereditary Angioedema Sales Market Share by Country in 2019

Figure 87. Latin America Hereditary Angioedema Revenue Market Share by Country in 2019

Figure 88. Mexico Hereditary Angioedema Sales Growth Rate (2015-2020) (MT)

Figure 89. Mexico Hereditary Angioedema Revenue Growth Rate (2015-2020) (US$ Million)

Figure 90. Brazil Hereditary Angioedema Sales Growth Rate (2015-2020) (MT)

Figure 91. Brazil Hereditary Angioedema Revenue Growth Rate (2015-2020) (US$ Million)

Figure 92. Argentina Hereditary Angioedema Sales Growth Rate (2015-2020) (MT)

Figure 93. Argentina Hereditary Angioedema Revenue Growth Rate (2015-2020) (US$ Million)

Figure 94. Latin America Hereditary Angioedema Market Share by Type in 2019

Figure 95. Latin America Hereditary Angioedema Market Share by Application in 2019

Figure 96. Middle East and Africa Hereditary Angioedema Sales Growth Rate 2015-2020 (MT)

Figure 97. Middle East and Africa Hereditary Angioedema Revenue Growth Rate 2015-2020 (US$ Million)

Figure 98. Middle East and Africa Hereditary Angioedema Sales Market Share by Country in 2019

Figure 99. Middle East and Africa Hereditary Angioedema Revenue Market Share by Country in 2019

Figure 100. Turkey Hereditary Angioedema Sales Growth Rate (2015-2020) (MT)

Figure 101. Turkey Hereditary Angioedema Revenue Growth Rate (2015-2020) (US$ Million)

Figure 102. Saudi Arabia Hereditary Angioedema Sales Growth Rate (2015-2020) (MT)

Figure 103. Saudi Arabia Hereditary Angioedema Revenue Growth Rate (2015-2020) (US$ Million)

Figure 104. U.A.E Hereditary Angioedema Sales Growth Rate (2015-2020) (MT)

Figure 105. U.A.E Hereditary Angioedema Revenue Growth Rate (2015-2020) (US$ Million)

Figure 106. Middle East and Africa Hereditary Angioedema Market Share by Type in 2019

Figure 107. Middle East and Africa Hereditary Angioedema Market Share by Application in 2019

Figure 108. North America Hereditary Angioedema Sales Growth Rate Forecast (2021-2026) (MT)

Figure 109. North America Hereditary Angioedema Revenue Growth Rate Forecast (2021-2026) (US$ Million)

Figure 110. Europe Hereditary Angioedema Sales Growth Rate Forecast (2021-2026) (MT)

Figure 111. Europe Hereditary Angioedema Revenue Growth Rate Forecast (2021-2026) (US$ Million)

Figure 112. Asia Pacific Hereditary Angioedema Sales Growth Rate Forecast (2021-2026) (MT)

Figure 113. Asia Pacific Hereditary Angioedema Revenue Growth Rate Forecast (2021-2026) (US$ Million)

Figure 114. Latin America Hereditary Angioedema Sales Growth Rate Forecast (2021-2026) (MT)

Figure 115. Latin America Hereditary Angioedema Revenue Growth Rate Forecast (2021-2026) (US$ Million)

Figure 116. Middle East and Africa Hereditary Angioedema Sales Growth Rate Forecast (2021-2026) (MT)

Figure 117. Middle East and Africa Hereditary Angioedema Revenue Growth Rate Forecast (2021-2026) (US$ Million)

Figure 118. Porter's Five Forces Analysis

Figure 119. Channels of Distribution

Figure 120. Distributors Profiles

Figure 121. Bottom-up and Top-down Approaches for This Report

Figure 122. Data Triangulation

Figure 123. Key Executives Interviewed

Pharming Group NV

Takeda

CSL Limited

iBio Inc.

BioCryst Pharmaceuticals, Inc.

Ionis Pharmaceuticals, Inc.

CHOOSE YOUR BUYING OPTION COVID-19 Revised Pricing Of the Month

SECURITY ASSUREDpayment image

Frequently Asked Questions ?

  • A license granted to one user.

    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License

    A license granted to multiple users.

  • Site License

    A license granted to a single business site/establishment.

  • Corporate License, Global License

    A license granted to all employees within organisation access to the product.

  • Upto Working 24 to 48 hrs

  • Upto 72 hrs max - Weekends and Public Holidays

  • Online Payments with PayPal and CCavenue

  • Wire Transfer/Bank Transfer

  • Email

  • Hard Copy

CHECK TODAYS BEST PRICE

BEST PRICE: $2925

SOME OF OUR CLIENTS

OUR KEY POINTS

  • Comprehensive Research

    Offers Penetrative insights & holistic understanding of the market

  • Data Accuracy & Reliability

    Strictly follows the Research Meth-odology for flawless results

  • Competitive Pricing

    Ensure the best and affordable pricing

  • Security & Confidentiality

    All your transactions are secured end-to-end, ensuring a satisfactory purchase